Can COVID‐19 cause atypical forms of pityriasis rosea refractory to conventional therapies?
Fabrizio Martora, Vincenzo Picone, Luigi Fornaro, Gabriella Fabbrocini, Claudio Marasca
Abstract
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Topics & Concepts
Pityriasis roseaRashMedicineDermatologyEtiologyVirologyRefractory (planetary science)VirusRespiratory tract infectionsCoronavirus disease 2019 (COVID-19)Respiratory systemImmunologyPathologyInternal medicineBiologyDiseaseAstrobiologyInfectious disease (medical specialty)Dermatological and COVID-19 studiesParvovirus B19 Infection StudiesAutoimmune and Inflammatory Disorders